Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) are a well-established treatment option for the treatment of T2D
Vial technique does require more attention than a pen device, especially for new patients
What the EMA Found and Why It Matters The EMAs Pharmacovigilance Risk Assessment Committee (PRAC) completed an exhaustive review of semaglutide, including data from clinical trials, post-marketing surveillance, non-clinical studies, and medical literature, and concluded that NAION is a very rare but real adverse effect of taking semaglutide
If youre considering taking semaglutide while breastfeeding, work with your provider to balance the benefits and potential problems for you and your infant to decide whether to start or continue taking it or not
Ozempic can cause side effects, including constipation, diarrhea, nausea, vomiting, and stomach pain
Understanding tirzepatide color variations helps identify your specific formulation